Large gap with delayed quotes
|
Last quote
12/27/2024 -
17:35:26
|
Bid
12/27/2024 -
17:29:55
|
Bid Volume |
Ask
12/27/2024 -
17:30:00
|
Ask Volume |
|---|---|---|---|---|
|
24.96
+0.20
(
+0.81% )
|
24.98
|
109 |
25.04
|
26 |
Analysis date: 24.12.2024
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 20.12.2024.
Interest
Very weak
Very weak
Very weak interest since 13.12.2024.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 13.12.2024 at a price of 24.00.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 01.11.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-8.13%
-8.13%
The four week relative underperformance versus STOXX600 is 8.13%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 20.12.2024.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.55%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.72%.
Mkt Cap in $bn
3.88
3.88
With a market capitalization between $2 & $8bn, SCHOTT PHARMA is considered a mid-cap stock.
G/PE Ratio
1.03
1.03
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
16.74
16.74
The estimated PE is for the year 2027.
LT Growth
16.48%
16.48%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
0.70%
0.70%
The twelve month estimated dividend yield represents 11.70% of earnings forecasts.
Beta
38
38
For 1% of index variation, the stock varies on average by 0.38%.
Correlation
0.10
0.10
Stock movements are totally independent of index variations.
Value at Risk
2.01
2.01
The value at risk is estimated at EUR 2.01. The risk is therefore 8.12%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.07.2024
02.07.2024